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Résumé en
anglais
Rheumatoid anemia is a typical example of anemia of chronic disease. It differs from
other forms of anemia, such as iron deficiency anemia or iatrogenic anemia.
Rheumatoid anemia is normochromic, normocytic or, less often, microcytic,
aregenerative, and accompanied with thrombocytosis. Serum transferrin levels are
normal or low, transferrin saturation is decreased, serum ferritin levels are normal or
high, the soluble transferrin receptor (sTfR) is not increased (a distinguishing feature
with iron deficiency anemia), and the sTfR/log ferritin ratio is lower than 1. This
review discusses the prevalence and impact of rheumatoid anemia based on a review
of the literature. Iron metabolism, absorption, diffusion, storage, and use by the bone
marrow are described using published data on transferrin, ferritin, and hepcidin.
Hepcidin is now recognized as a key factor in rheumatoid anemia, in conjunction with
the cytokine interleukin-6 (IL-6). Hepcidin is a hormone that lowers serum iron levels
and regulates iron transport across membranes, preventing iron from exiting the
enterocytes, macrophages, and hepatocytes. In addition, hepcidin inhibits intestinal
iron absorption and iron release from macrophages and hepatocytes. The action of
hepcidin is mediated by binding to the iron exporter ferroportin. Hepcidin expression
in the liver is dependent on the protein hemojuvelin. Inflammation leads to increased
hepcidin production via IL-6, whereas iron deficiency and factors associated with
increased erythropoiesis (hypoxia, bleeding, hemolysis, dyserythropoiesis) suppress
the production of hepcidin. Data from oncology studies and the effects of
recombinant human IL-6 support a causal link between IL-6 production and the
development of anemia in patients with chronic disease. IL-6 diminishes the
proportion of nucleated erythroid cells in the bone marrow and lowers the serum iron
level, and these abnormalities can be corrected by administering an IL-6 antagonist.
IL-6 stimulates hepcidin gene transcription, most notably in the hepatocytes. Studies
involving human hepatocyte exposure to a panel of cytokines showed that IL-6, but
not TNFα or IL-1, induced the production of hepcidin mRNA. Recent data on hepcidin
level variations in patients with rheumatoid arthritis are reviewed. Rheumatoid
anemia is best corrected by ensuring optimal control of systemic disease activity. The
role for iron supplementation (per os or intravenously) and erythropoietin in the
treatment of rheumatoid anemia is discussed. Given the cascade of interactions
linking IL-6, hepcidin, and anemia, IL-6 antagonists hold considerable promise for the
management of rheumatoid anemia.
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